4D Pharma Research Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
29
- Latest Deal Type
-
Corporate
- Latest Deal Amount
-
$2.05M
4D Pharma Research General Information
Description
Developer of Biotherapeutics for the treatment of autoimmune diseases. The company develops approved Biotherapeutic products with proven efficacy for the treatment and management of debilitating paediatric inflammatory bowel diseases and other autoimmune diseases.
Contact Information
Website
www.gt-biologics.comCorporate Office
- Life Sciences Innovation Building
- Cornhill Road
- Aberdeen AB25 2ZS
- Scotland, United Kingdom
Corporate Office
- Life Sciences Innovation Building
- Cornhill Road
- Aberdeen AB25 2ZS
- Scotland, United Kingdom
4D Pharma Research Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Corporate | 10-Jun-2014 | $2.05M | Completed | Product Development | ||
| 4. Early Stage VC | 04-Dec-2013 | Completed | Product Development | |||
| 3. Later Stage VC | 08-Jul-2013 | Completed | Product Development | |||
| 2. Early Stage VC | 26-Nov-2012 | $450K | $848K | Completed | Product Development | |
| 1. Seed Round | 26-Mar-2010 | $398K | $398K | Completed | Startup |
4D Pharma Research Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary A | ||||||||
| Growth | ||||||||
| Ordinary | 79,059 | $10.23 | $10.23 | 1x | $10.23 | 77.21% |
4D Pharma Research Patents
4D Pharma Research Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202204110-D0 | Compositions comprising bacterial strains | Inactive | 23-Mar-2022 | ||
| WO-2023072968-A1 | Compositions comprising bacterial strains | Inactive | 25-Oct-2021 | ||
| WO-2023041203-A1 | Compositions comprising bacterial strains | Inactive | 14-Sep-2021 | ||
| WO-2023041574-A1 | Compositions comprising bacterial strains | Inactive | 14-Sep-2021 | ||
| GB-202017110-D0 | Compositions comprising of bacterial strains | Inactive | 28-Oct-2020 |
4D Pharma Research Signals
4D Pharma Research Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aquarius Equity Partners | Venture Capital | Minority | ||
| Genomia Fund | Venture Capital | Minority | ||
| Scottish Enterprise | Growth/Expansion | Minority | ||
| University of Aberdeen Endowment | Limited Partner | Minority |
4D Pharma Research FAQs
-
When was 4D Pharma Research founded?
4D Pharma Research was founded in 2008.
-
Where is 4D Pharma Research headquartered?
4D Pharma Research is headquartered in Aberdeen, United Kingdom.
-
What is the size of 4D Pharma Research?
4D Pharma Research has 29 total employees.
-
What industry is 4D Pharma Research in?
4D Pharma Research’s primary industry is Drug Discovery.
-
Is 4D Pharma Research a private or public company?
4D Pharma Research is a Private company.
-
What is the current valuation of 4D Pharma Research?
The current valuation of 4D Pharma Research is .
-
What is 4D Pharma Research’s current revenue?
The current revenue for 4D Pharma Research is .
-
How much funding has 4D Pharma Research raised over time?
4D Pharma Research has raised $4.09M.
-
Who are 4D Pharma Research’s investors?
Aquarius Equity Partners, Genomia Fund, Scottish Enterprise, and University of Aberdeen Endowment have invested in 4D Pharma Research.
-
When was 4D Pharma Research acquired?
4D Pharma Research was acquired on 10-Jun-2014.
-
Who acquired 4D Pharma Research?
4D Pharma Research was acquired by 4D pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process